North America Biosimilars Market Size, by Country (2024–2032)

Free

in USD Million

North America Biosimilars Market: Strategic Developments and Forecasts (2024-2032)

Published by MMR Statistics Reserch Team, November 2025

Strategic healthcare adjustments shaped the North America Biosimilars Market in 2024, with the United States recorded USD 11,940.74 million, Canada reached USD 1,276.07 million, and Mexico at USD 775.15 million. The 2025 landscape of the North America Biosimilars Market is estimated to advance, with the United States at USD 13,200.44 million. From 2026 to 2032, values are projected to increase, reaching USD 29,868.93 million by 2032, as the United States continues to maintain accelerated biosimilar approvals and broader clinical adoption.

OTHER STATISTICS ON TOPIC

Biosimilars

More statistics on Biosimilars

Download

Information

Unit

in USD Million

Region

North America

Time Period

2024-2032

Source Name

Maximize Market Research Pvt. Ltd

Source Link

http://www.maximizemarketresearch.com

Publisher Name

Maximize Market Research Pvt. Ltd

Publisher Link

http://www.maximizemarketresearch.com

Related reports

Market Research Reports on Biosimilars

Explore published research tied to this statistic's topic. Open the featured edition or jump into another region without leaving the page.

Open featured report

Subscriptions

Stay ahead of Biosimilars with tailored access

Sample free-tier statistics or unlock premium coverage for this topic with team-friendly usage rights.

Discover

Try free-tier statistics before committing to a plan.

Start for Free

Professional

Unlock premium coverage across this topic with analyst support.

Select Plan

Contact our team

Need a bespoke deep-dive on Biosimilars?

Tell us about your KPIs and coverage priorities. We can tailor a briefing, share methodology notes, or build a custom dataset that complements the reports and statistics you are browsing.

Talk with an analyst